<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02951143</url>
  </required_header>
  <id_info>
    <org_study_id>R01DA042535</org_study_id>
    <nct_id>NCT02951143</nct_id>
  </id_info>
  <brief_title>Abuse Liability of Reduced Nicotine Content Cigarettes Within a Complex Tobacco Marketplace</brief_title>
  <official_title>Abuse Liability of Reduced Nicotine Content Cigarettes Within a Complex Tobacco Marketplace</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Virginia Polytechnic Institute and State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Kentucky</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Virginia Polytechnic Institute and State University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Tobacco regulatory policies can have unanticipated consequences; therefore, methods that&#xD;
      would permit prospective estimates of the effects of potential tobacco regulations are&#xD;
      necessary for the development of tobacco regulatory science. The goal of this project is to&#xD;
      experimentally assess how smokers purchase and consume reduced-nicotine cigarettes. In&#xD;
      experiment 1, we will investigate how purchasing/consuming reduced-nicotine cigarettes is&#xD;
      related to nicotine content and absorption. In experiment 2, we will investigate how&#xD;
      purchasing/consuming changes when other nicotine products are available in an experimental&#xD;
      marketplace setting. The proposed projects can directly inform tobacco regulation by&#xD;
      providing estimates of the real-world effects of novel policies.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The specific objective in Experiment 1 is to examine the effect of nicotine content (0.4&#xD;
      mg/g, 1.4 mg/g, 2.5 mg/g, 5.6 mg/g, and 17.4 mg/g of tobacco) and blood nicotine absorption&#xD;
      on laboratory behavioral economic measures of demand intensity and elasticity. Under&#xD;
      double-blind conditions, we will examine the relationship between plasma nicotine and&#xD;
      cigarette demand as a function of the dose of the nicotine in the cigarettes. Regular&#xD;
      cigarette smokers will consume, on separate sessions, controlled puffs of a cigarette&#xD;
      containing a blinded dose of nicotine then complete a cigarette purchase task, our measure of&#xD;
      value, while plasma nicotine is measured. We hypothesize that cigarette demand will be&#xD;
      associated with dose and level of circulating nicotine, but in a nonlinear fashion such that&#xD;
      consumption of very low dose cigarettes will not be predicted by nicotine dose or intake&#xD;
      alone.&#xD;
&#xD;
      To inform how various products may interact, we have developed and tested a novel method&#xD;
      called the Experimental Tobacco Marketplace. The Experimental Tobacco Marketplace is a&#xD;
      systematic extension of similar marketplace methods used with other consumer products (e.g.,&#xD;
      food marketplaces used in obesity and other nutrition-related research; Epstein, Dearing,&#xD;
      Roba, &amp; Finkelstein, 2010). In experimental marketplaces, multiple products are available and&#xD;
      the experimenter controls the prices for each. These marketplaces can be either physical or&#xD;
      virtual stores (similar to online retailers) and permit the examination of demand elasticity&#xD;
      and intensity and degree of substitution or complementarity in consumer behavior under&#xD;
      conditions that approximate naturalistic settings.&#xD;
&#xD;
      Experiment 2 will extend findings from the first experiment examining the effects of&#xD;
      different concentrations of nicotine in cigarettes (0.4mg/g, 1.4mg/g, 2.5mg/g, 5.6mg/g,&#xD;
      17.4mg/g) and blood nictotine absorption on laboratory behavioral economic demand measures.&#xD;
      Employing this innovative Experimental Tobacco Marketplace, we propose to examine&#xD;
      reduced-nicotine cigarettes under the following conditions: 1) control conditions where lower&#xD;
      dose nicotine cigarettes are the only available product in the Experimental Tobacco&#xD;
      Marketplace and where the tobacco marketplace is similar to the current real-world&#xD;
      marketplace (i.e., no lower dose nicotine cigarettes, but a variety of other tobacco&#xD;
      products); 2) lower dose nicotine cigarettes are available with a number of other nicotine&#xD;
      products excluding conventional cigarettes; and 3) lower dose nicotine cigarettes are&#xD;
      available with a number of other nicotine products including conventional cigarettes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2017</start_date>
  <completion_date type="Actual">November 2019</completion_date>
  <primary_completion_date type="Actual">November 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Estimated Cigarettes Taken at Free Price Derived From the Cigarette Purchase Task</measure>
    <time_frame>10 minutes after cigarette administration</time_frame>
    <description>The Cigarette Purchase Task is a behavioral economic measure of abuse liability that consists of a series of hypothetical questions asking participants to indicate how many cigarettes they would purchase for their own consumption across a range of cigarette prices. Participants smoked one cigarette and then were asked to report how many cigarettes they would smoke within a 24 hour period at the following prices: $0.00 (free), $0.01, $0.05, $0.10, $0.25, $0.50, $1, $2, $5, $10, $25, $50, $100, $200. Nonlinear regression was then used to estimate the number of cigarettes participants would take when they were free using the equation by Koffarnus et al. (2015; doi:10.1037/pha0000045). The outcome is the logarithmically transformed number of cigarettes.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Blood Nicotine Content Over the Course of the Session</measure>
    <time_frame>Each session (6 sessions total) with at least 2 days between each session.</time_frame>
    <description>For participants in the single arm only, blood will be collected throughout each session and analyzed for nicotine content. The change in blood nicotine content over the course of the session will be compared among the six sessions where different cigarettes were administered. Blood nicotine (expressed in ng/mL) at minute 0 was subtracted from blood nicotine at minutes 10, 15, 20, 30, 45, and 60 to yield a change in blood nicotine (negative values were truncated to 0) at each of the time points. Using these change in blood nicotine values, we calculated Area Under the Curve (AUC) via the trapezoidal rule, which resulted in a singular number (total change in blood nicotine over the course of each experimental session) in our primary outcome measure.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Experimental Marketplace Purchases</measure>
    <time_frame>Sessions 2-5 with each session conducted one week apart (for 4 weeks total)</time_frame>
    <description>In all arms except the single arm, measures of quantities of experimental cigarettes and other nicotine products will be obtained.</description>
  </primary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">305</enrollment>
  <condition>Substance-Related Disorders</condition>
  <arm_group>
    <arm_group_label>Single arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All participants will complete the same experimental events across 6 laboratory sessions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>0.4 mg/g Concentration</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this arm will experience the 0.4 mg/g Concentration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>1.3 mg/g Concentration</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this arm will experience the 1.3 mg/g Concentration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2.4 mg/g Concentration</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this arm will experience the 2.4 mg/g Concentration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>5.2 mg/g Concentration</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this arm will experience the 5.2 mg/g Concentration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>15.8 mg/g Concentration</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this arm will experience the 15.8 mg/g Concentration</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>SPECTRUM cigarettes</intervention_name>
    <description>Across six laboratory sessions, participants will consume 10 puffs of either their usual brand of cigarette (one session) or a SPECTRUM cigarette (five sessions) with a nicotine yield varying from 0.03 to 0.70 and either menthol (TPMF codes NRC 103, NRC 201, NRC 301, NRC 401, and NRC 601) or tobacco (TPMF codes NRC 102, NRC 200, NRC 300, NRC 400, and NRC 600) flavor, depending on preference. This will be followed by the collection of blood nicotine content and a cigarette purchase task.</description>
    <arm_group_label>Single arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>SPECTRUM cigarettes between</intervention_name>
    <description>Participants will be assigned one of the nicotine concentrations of a SPECTRUM cigarette. They will complete a cigarette purchase task and make real purchases for the next week. Participants will return and make purchases again, repeating 4 times.</description>
    <arm_group_label>0.4 mg/g Concentration</arm_group_label>
    <arm_group_label>1.3 mg/g Concentration</arm_group_label>
    <arm_group_label>15.8 mg/g Concentration</arm_group_label>
    <arm_group_label>2.4 mg/g Concentration</arm_group_label>
    <arm_group_label>5.2 mg/g Concentration</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  smoke at least 5 cigarettes per day&#xD;
&#xD;
          -  have a breath carbon monoxide (CO) level of at least 10 ppm at intake&#xD;
&#xD;
          -  no immediate plans to quit smoking.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnant, lactating, plans to become pregnant&#xD;
&#xD;
          -  weigh more than 110lbs (experiment 1 only)&#xD;
&#xD;
          -  have plans to move out of the area during the course of the experiment&#xD;
&#xD;
        To see if you are eligible, use the following confidential link:&#xD;
        http://vtcri.info/arrcclinicaltrials&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Warren K Bickel, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Virginia Polytechnic Institute and State University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fralin Biomedical Research Institute at VTC</name>
      <address>
        <city>Roanoke</city>
        <state>Virginia</state>
        <zip>24016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>October 27, 2016</study_first_submitted>
  <study_first_submitted_qc>October 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 1, 2016</study_first_posted>
  <results_first_submitted>April 22, 2021</results_first_submitted>
  <results_first_submitted_qc>August 26, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">September 22, 2021</results_first_posted>
  <last_update_submitted>August 26, 2021</last_update_submitted>
  <last_update_submitted_qc>August 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Virginia Polytechnic Institute and State University</investigator_affiliation>
    <investigator_full_name>Warren K. Bickel</investigator_full_name>
    <investigator_title>Professor and Director</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Substance-Related Disorders</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol, Statistical Analysis Plan, and Informed Consent Form</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>November 4, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/43/NCT02951143/Prot_SAP_ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Single Arm</title>
          <description>All participants will complete the same experimental events across 6 laboratory sessions.&#xD;
SPECTRUM cigarettes: Across six laboratory sessions, participants will consume 10 puffs of either their usual brand of cigarette (one session) or a SPECTRUM cigarette (five sessions) with a nicotine yield varying from 0.03 to 0.70 and either menthol (TPMF codes NRC 103, NRC 201, NRC 301, NRC 401, and NRC 601) or tobacco (TPMF codes NRC 102, NRC 200, NRC 300, NRC 400, and NRC 600) flavor, depending on preference. This will be followed by the collection of blood nicotine content and a cigarette purchase task.</description>
        </group>
        <group group_id="P2">
          <title>0.4 mg/g Concentration</title>
          <description>Participants in this arm will experience the 0.4 mg/g Concentration&#xD;
SPECTRUM cigarettes between: Participants will be assigned one of the nicotine concentrations of a SPECTRUM cigarette. They will complete a cigarette purchase task and make real purchases for the next week. Participants will return and make purchases again, repeating 4 times.</description>
        </group>
        <group group_id="P3">
          <title>1.3 mg/g Concentration</title>
          <description>Participants in this arm will experience the 1.3 mg/g Concentration&#xD;
SPECTRUM cigarettes between: Participants will be assigned one of the nicotine concentrations of a SPECTRUM cigarette. They will complete a cigarette purchase task and make real purchases for the next week. Participants will return and make purchases again, repeating 4 times.</description>
        </group>
        <group group_id="P4">
          <title>2.4 mg/g Concentration</title>
          <description>Participants in this arm will experience the 2.4 mg/g Concentration&#xD;
SPECTRUM cigarettes between: Participants will be assigned one of the nicotine concentrations of a SPECTRUM cigarette. They will complete a cigarette purchase task and make real purchases for the next week. Participants will return and make purchases again, repeating 4 times.</description>
        </group>
        <group group_id="P5">
          <title>5.2 mg/g Concentration</title>
          <description>Participants in this arm will experience the 5.2 mg/g Concentration&#xD;
SPECTRUM cigarettes between: Participants will be assigned one of the nicotine concentrations of a SPECTRUM cigarette. They will complete a cigarette purchase task and make real purchases for the next week. Participants will return and make purchases again, repeating 4 times.</description>
        </group>
        <group group_id="P6">
          <title>15.8 mg/g Concentration</title>
          <description>Participants in this arm will experience the 15.8 mg/g Concentration&#xD;
SPECTRUM cigarettes between: Participants will be assigned one of the nicotine concentrations of a SPECTRUM cigarette. They will complete a cigarette purchase task and make real purchases for the next week. Participants will return and make purchases again, repeating 4 times.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="97"/>
                <participants group_id="P2" count="41"/>
                <participants group_id="P3" count="47"/>
                <participants group_id="P4" count="39"/>
                <participants group_id="P5" count="37"/>
                <participants group_id="P6" count="44"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="36"/>
                <participants group_id="P2" count="32"/>
                <participants group_id="P3" count="29"/>
                <participants group_id="P4" count="30"/>
                <participants group_id="P5" count="31"/>
                <participants group_id="P6" count="29"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="61"/>
                <participants group_id="P2" count="9"/>
                <participants group_id="P3" count="18"/>
                <participants group_id="P4" count="9"/>
                <participants group_id="P5" count="6"/>
                <participants group_id="P6" count="15"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Single Arm</title>
          <description>All participants will complete the same experimental events across 6 laboratory sessions.&#xD;
SPECTRUM cigarettes: Across six laboratory sessions, participants will consume 10 puffs of either their usual brand of cigarette (one session) or a SPECTRUM cigarette (five sessions) with a nicotine yield varying from 0.03 to 0.70 and either menthol (TPMF codes NRC 103, NRC 201, NRC 301, NRC 401, and NRC 601) or tobacco (TPMF codes NRC 102, NRC 200, NRC 300, NRC 400, and NRC 600) flavor, depending on preference. This will be followed by the collection of blood nicotine content and a cigarette purchase task.</description>
        </group>
        <group group_id="B2">
          <title>0.4 mg/g Concentration</title>
          <description>Participants in this arm will experience the 0.4 mg/g Concentration&#xD;
SPECTRUM cigarettes between: Participants will be assigned one of the nicotine concentrations of a SPECTRUM cigarette. They will complete a cigarette purchase task and make real purchases for the next week. Participants will return and make purchases again, repeating 4 times.</description>
        </group>
        <group group_id="B3">
          <title>1.3 mg/g Concentration</title>
          <description>Participants in this arm will experience the 1.3 mg/g Concentration&#xD;
SPECTRUM cigarettes between: Participants will be assigned one of the nicotine concentrations of a SPECTRUM cigarette. They will complete a cigarette purchase task and make real purchases for the next week. Participants will return and make purchases again, repeating 4 times.</description>
        </group>
        <group group_id="B4">
          <title>2.4 mg/g Concentration</title>
          <description>Participants in this arm will experience the 2.4 mg/g Concentration&#xD;
SPECTRUM cigarettes between: Participants will be assigned one of the nicotine concentrations of a SPECTRUM cigarette. They will complete a cigarette purchase task and make real purchases for the next week. Participants will return and make purchases again, repeating 4 times.</description>
        </group>
        <group group_id="B5">
          <title>5.2 mg/g Concentration</title>
          <description>Participants in this arm will experience the 5.2 mg/g Concentration&#xD;
SPECTRUM cigarettes between: Participants will be assigned one of the nicotine concentrations of a SPECTRUM cigarette. They will complete a cigarette purchase task and make real purchases for the next week. Participants will return and make purchases again, repeating 4 times.</description>
        </group>
        <group group_id="B6">
          <title>15.8 mg/g Concentration</title>
          <description>Participants in this arm will experience the 15.8 mg/g Concentration&#xD;
SPECTRUM cigarettes between: Participants will be assigned one of the nicotine concentrations of a SPECTRUM cigarette. They will complete a cigarette purchase task and make real purchases for the next week. Participants will return and make purchases again, repeating 4 times.</description>
        </group>
        <group group_id="B7">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="36"/>
            <count group_id="B2" value="32"/>
            <count group_id="B3" value="29"/>
            <count group_id="B4" value="30"/>
            <count group_id="B5" value="31"/>
            <count group_id="B6" value="29"/>
            <count group_id="B7" value="187"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <population>Each group (Various Concentrations and Single Arm) was analyzed separately.</population>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <title>Various Concentrations</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="32"/>
                    <count group_id="B3" value="29"/>
                    <count group_id="B4" value="30"/>
                    <count group_id="B5" value="31"/>
                    <count group_id="B6" value="29"/>
                    <count group_id="B7" value="151"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B2" value="41" lower_limit="32.75" upper_limit="46.25"/>
                    <measurement group_id="B3" value="37" lower_limit="28" upper_limit="49"/>
                    <measurement group_id="B4" value="46" lower_limit="34" upper_limit="51"/>
                    <measurement group_id="B5" value="42" lower_limit="36" upper_limit="51"/>
                    <measurement group_id="B6" value="39" lower_limit="34" upper_limit="48"/>
                    <measurement group_id="B7" value="41" lower_limit="33" upper_limit="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Single Arm</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="36"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                    <count group_id="B4" value="0"/>
                    <count group_id="B5" value="0"/>
                    <count group_id="B6" value="0"/>
                    <count group_id="B7" value="36"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38.5" lower_limit="33" upper_limit="48.25"/>
                    <measurement group_id="B7" value="38.5" lower_limit="33" upper_limit="48.25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="36"/>
                    <count group_id="B2" value="32"/>
                    <count group_id="B3" value="29"/>
                    <count group_id="B4" value="30"/>
                    <count group_id="B5" value="31"/>
                    <count group_id="B6" value="29"/>
                    <count group_id="B7" value="187"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="12"/>
                    <measurement group_id="B4" value="16"/>
                    <measurement group_id="B5" value="15"/>
                    <measurement group_id="B6" value="13"/>
                    <measurement group_id="B7" value="87"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="17"/>
                    <measurement group_id="B4" value="14"/>
                    <measurement group_id="B5" value="16"/>
                    <measurement group_id="B6" value="16"/>
                    <measurement group_id="B7" value="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Race</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="36"/>
                    <count group_id="B2" value="32"/>
                    <count group_id="B3" value="29"/>
                    <count group_id="B4" value="30"/>
                    <count group_id="B5" value="31"/>
                    <count group_id="B6" value="29"/>
                    <count group_id="B7" value="187"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="19"/>
                    <measurement group_id="B4" value="20"/>
                    <measurement group_id="B5" value="24"/>
                    <measurement group_id="B6" value="17"/>
                    <measurement group_id="B7" value="128"/>
                  </measurement_list>
                </category>
                <category>
                  <title>African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="9"/>
                    <measurement group_id="B4" value="9"/>
                    <measurement group_id="B5" value="7"/>
                    <measurement group_id="B6" value="10"/>
                    <measurement group_id="B7" value="51"/>
                  </measurement_list>
                </category>
                <category>
                  <title>American Indian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                    <measurement group_id="B7" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="2"/>
                    <measurement group_id="B7" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="36"/>
                    <count group_id="B2" value="32"/>
                    <count group_id="B3" value="29"/>
                    <count group_id="B4" value="30"/>
                    <count group_id="B5" value="31"/>
                    <count group_id="B6" value="29"/>
                    <count group_id="B7" value="187"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="32"/>
                    <measurement group_id="B3" value="29"/>
                    <measurement group_id="B4" value="30"/>
                    <measurement group_id="B5" value="31"/>
                    <measurement group_id="B6" value="29"/>
                    <measurement group_id="B7" value="187"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Estimated Cigarettes Taken at Free Price Derived From the Cigarette Purchase Task</title>
        <description>The Cigarette Purchase Task is a behavioral economic measure of abuse liability that consists of a series of hypothetical questions asking participants to indicate how many cigarettes they would purchase for their own consumption across a range of cigarette prices. Participants smoked one cigarette and then were asked to report how many cigarettes they would smoke within a 24 hour period at the following prices: $0.00 (free), $0.01, $0.05, $0.10, $0.25, $0.50, $1, $2, $5, $10, $25, $50, $100, $200. Nonlinear regression was then used to estimate the number of cigarettes participants would take when they were free using the equation by Koffarnus et al. (2015; doi:10.1037/pha0000045). The outcome is the logarithmically transformed number of cigarettes.</description>
        <time_frame>10 minutes after cigarette administration</time_frame>
        <population>Only those participants in the single arm completed this task.</population>
        <group_list>
          <group group_id="O1">
            <title>Single Arm</title>
            <description>All participants will complete the same experimental events across 6 laboratory sessions.&#xD;
SPECTRUM cigarettes: Across six laboratory sessions, participants will consume 10 puffs of either their usual brand of cigarette (one session) or a SPECTRUM cigarette (five sessions) with a nicotine yield varying from 0.03 to 0.70 and either menthol (TPMF codes NRC 103, NRC 201, NRC 301, NRC 401, and NRC 601) or tobacco (TPMF codes NRC 102, NRC 200, NRC 300, NRC 400, and NRC 600) flavor, depending on preference. This will be followed by the collection of blood nicotine content and a cigarette purchase task.</description>
          </group>
          <group group_id="O2">
            <title>0.4 mg/g Concentration</title>
            <description>Participants in this arm will experience the 0.4 mg/g Concentration&#xD;
SPECTRUM cigarettes between: Participants will be assigned one of the nicotine concentrations of a SPECTRUM cigarette. They will complete a cigarette purchase task and make real purchases for the next week. Participants will return and make purchases again, repeating 4 times.</description>
          </group>
          <group group_id="O3">
            <title>1.3 mg/g Concentration</title>
            <description>Participants in this arm will experience the 1.3 mg/g Concentration&#xD;
SPECTRUM cigarettes between: Participants will be assigned one of the nicotine concentrations of a SPECTRUM cigarette. They will complete a cigarette purchase task and make real purchases for the next week. Participants will return and make purchases again, repeating 4 times.</description>
          </group>
          <group group_id="O4">
            <title>2.4 mg/g Concentration</title>
            <description>Participants in this arm will experience the 2.4 mg/g Concentration&#xD;
SPECTRUM cigarettes between: Participants will be assigned one of the nicotine concentrations of a SPECTRUM cigarette. They will complete a cigarette purchase task and make real purchases for the next week. Participants will return and make purchases again, repeating 4 times.</description>
          </group>
          <group group_id="O5">
            <title>5.2 mg/g Concentration</title>
            <description>Participants in this arm will experience the 5.2 mg/g Concentration&#xD;
SPECTRUM cigarettes between: Participants will be assigned one of the nicotine concentrations of a SPECTRUM cigarette. They will complete a cigarette purchase task and make real purchases for the next week. Participants will return and make purchases again, repeating 4 times.</description>
          </group>
          <group group_id="O6">
            <title>15.8 mg/g Concentration</title>
            <description>Participants in this arm will experience the 15.8 mg/g Concentration&#xD;
SPECTRUM cigarettes between: Participants will be assigned one of the nicotine concentrations of a SPECTRUM cigarette. They will complete a cigarette purchase task and make real purchases for the next week. Participants will return and make purchases again, repeating 4 times.</description>
          </group>
        </group_list>
        <measure>
          <title>Estimated Cigarettes Taken at Free Price Derived From the Cigarette Purchase Task</title>
          <description>The Cigarette Purchase Task is a behavioral economic measure of abuse liability that consists of a series of hypothetical questions asking participants to indicate how many cigarettes they would purchase for their own consumption across a range of cigarette prices. Participants smoked one cigarette and then were asked to report how many cigarettes they would smoke within a 24 hour period at the following prices: $0.00 (free), $0.01, $0.05, $0.10, $0.25, $0.50, $1, $2, $5, $10, $25, $50, $100, $200. Nonlinear regression was then used to estimate the number of cigarettes participants would take when they were free using the equation by Koffarnus et al. (2015; doi:10.1037/pha0000045). The outcome is the logarithmically transformed number of cigarettes.</description>
          <population>Only those participants in the single arm completed this task.</population>
          <units>Cigarettes (log transformed)</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
                <count group_id="O5" value="0"/>
                <count group_id="O6" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Usual Brand</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.50" spread=".0583"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>15.8mg/g</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.45" spread=".0555"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5.2mg/g</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.47" spread=".0538"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2.4mg/g</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.45" spread=".0678"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1.3mg/g</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.37" spread=".0975"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>0.4mg/g</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.35" spread=".0727"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Change in Blood Nicotine Content Over the Course of the Session</title>
        <description>For participants in the single arm only, blood will be collected throughout each session and analyzed for nicotine content. The change in blood nicotine content over the course of the session will be compared among the six sessions where different cigarettes were administered. Blood nicotine (expressed in ng/mL) at minute 0 was subtracted from blood nicotine at minutes 10, 15, 20, 30, 45, and 60 to yield a change in blood nicotine (negative values were truncated to 0) at each of the time points. Using these change in blood nicotine values, we calculated Area Under the Curve (AUC) via the trapezoidal rule, which resulted in a singular number (total change in blood nicotine over the course of each experimental session) in our primary outcome measure.</description>
        <time_frame>Each session (6 sessions total) with at least 2 days between each session.</time_frame>
        <population>Only participants in the single arm had blood collected.</population>
        <group_list>
          <group group_id="O1">
            <title>Single Arm</title>
            <description>All participants will complete the same experimental events across 6 laboratory sessions.&#xD;
SPECTRUM cigarettes: Across six laboratory sessions, participants will consume 10 puffs of either their usual brand of cigarette (one session) or a SPECTRUM cigarette (five sessions) with a nicotine yield varying from 0.03 to 0.70 and either menthol (TPMF codes NRC 103, NRC 201, NRC 301, NRC 401, and NRC 601) or tobacco (TPMF codes NRC 102, NRC 200, NRC 300, NRC 400, and NRC 600) flavor, depending on preference. This will be followed by the collection of blood nicotine content and a cigarette purchase task.</description>
          </group>
          <group group_id="O2">
            <title>0.4 mg/g Concentration</title>
            <description>Participants in this arm will experience the 0.4 mg/g Concentration&#xD;
SPECTRUM cigarettes between: Participants will be assigned one of the nicotine concentrations of a SPECTRUM cigarette. They will complete a cigarette purchase task and make real purchases for the next week. Participants will return and make purchases again, repeating 4 times.</description>
          </group>
          <group group_id="O3">
            <title>1.3 mg/g Concentration</title>
            <description>Participants in this arm will experience the 1.3 mg/g Concentration&#xD;
SPECTRUM cigarettes between: Participants will be assigned one of the nicotine concentrations of a SPECTRUM cigarette. They will complete a cigarette purchase task and make real purchases for the next week. Participants will return and make purchases again, repeating 4 times.</description>
          </group>
          <group group_id="O4">
            <title>2.4 mg/g Concentration</title>
            <description>Participants in this arm will experience the 2.4 mg/g Concentration&#xD;
SPECTRUM cigarettes between: Participants will be assigned one of the nicotine concentrations of a SPECTRUM cigarette. They will complete a cigarette purchase task and make real purchases for the next week. Participants will return and make purchases again, repeating 4 times.</description>
          </group>
          <group group_id="O5">
            <title>5.2 mg/g Concentration</title>
            <description>Participants in this arm will experience the 5.2 mg/g Concentration&#xD;
SPECTRUM cigarettes between: Participants will be assigned one of the nicotine concentrations of a SPECTRUM cigarette. They will complete a cigarette purchase task and make real purchases for the next week. Participants will return and make purchases again, repeating 4 times.</description>
          </group>
          <group group_id="O6">
            <title>15.8 mg/g Concentration</title>
            <description>Participants in this arm will experience the 15.8 mg/g Concentration&#xD;
SPECTRUM cigarettes between: Participants will be assigned one of the nicotine concentrations of a SPECTRUM cigarette. They will complete a cigarette purchase task and make real purchases for the next week. Participants will return and make purchases again, repeating 4 times.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Blood Nicotine Content Over the Course of the Session</title>
          <description>For participants in the single arm only, blood will be collected throughout each session and analyzed for nicotine content. The change in blood nicotine content over the course of the session will be compared among the six sessions where different cigarettes were administered. Blood nicotine (expressed in ng/mL) at minute 0 was subtracted from blood nicotine at minutes 10, 15, 20, 30, 45, and 60 to yield a change in blood nicotine (negative values were truncated to 0) at each of the time points. Using these change in blood nicotine values, we calculated Area Under the Curve (AUC) via the trapezoidal rule, which resulted in a singular number (total change in blood nicotine over the course of each experimental session) in our primary outcome measure.</description>
          <population>Only participants in the single arm had blood collected.</population>
          <units>ng/mL/session</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="0"/>
                <count group_id="O3" value="0"/>
                <count group_id="O4" value="0"/>
                <count group_id="O5" value="0"/>
                <count group_id="O6" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Usual Brand</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="551.31" spread="24.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>15.8mg/g</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="350.62" spread="24.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5.2mg/g</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="192.91" spread="24.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2.4mg/g</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57.11" spread="24.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1.3mg/g</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.18" spread="24.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>0.4mg/g</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.24" spread="24.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Experimental Marketplace Purchases</title>
        <description>In all arms except the single arm, measures of quantities of experimental cigarettes and other nicotine products will be obtained.</description>
        <time_frame>Sessions 2-5 with each session conducted one week apart (for 4 weeks total)</time_frame>
        <population>This single arm did not complete the Experimental Marketplace Purchases</population>
        <group_list>
          <group group_id="O1">
            <title>Single Arm</title>
            <description>All participants will complete the same experimental events across 6 laboratory sessions.&#xD;
SPECTRUM cigarettes: Across six laboratory sessions, participants will consume 10 puffs of either their usual brand of cigarette (one session) or a SPECTRUM cigarette (five sessions) with a nicotine yield varying from 0.03 to 0.70 and either menthol (TPMF codes NRC 103, NRC 201, NRC 301, NRC 401, and NRC 601) or tobacco (TPMF codes NRC 102, NRC 200, NRC 300, NRC 400, and NRC 600) flavor, depending on preference. This will be followed by the collection of blood nicotine content and a cigarette purchase task.</description>
          </group>
          <group group_id="O2">
            <title>0.4 mg/g Concentration</title>
            <description>Participants in this arm will experience the 0.4 mg/g Concentration&#xD;
SPECTRUM cigarettes between: Participants will be assigned one of the nicotine concentrations of a SPECTRUM cigarette. They will complete a cigarette purchase task and make real purchases for the next week. Participants will return and make purchases again, repeating 4 times.</description>
          </group>
          <group group_id="O3">
            <title>1.3 mg/g Concentration</title>
            <description>Participants in this arm will experience the 1.3 mg/g Concentration&#xD;
SPECTRUM cigarettes between: Participants will be assigned one of the nicotine concentrations of a SPECTRUM cigarette. They will complete a cigarette purchase task and make real purchases for the next week. Participants will return and make purchases again, repeating 4 times.</description>
          </group>
          <group group_id="O4">
            <title>2.4 mg/g Concentration</title>
            <description>Participants in this arm will experience the 2.4 mg/g Concentration&#xD;
SPECTRUM cigarettes between: Participants will be assigned one of the nicotine concentrations of a SPECTRUM cigarette. They will complete a cigarette purchase task and make real purchases for the next week. Participants will return and make purchases again, repeating 4 times.</description>
          </group>
          <group group_id="O5">
            <title>5.2 mg/g Concentration</title>
            <description>Participants in this arm will experience the 5.2 mg/g Concentration&#xD;
SPECTRUM cigarettes between: Participants will be assigned one of the nicotine concentrations of a SPECTRUM cigarette. They will complete a cigarette purchase task and make real purchases for the next week. Participants will return and make purchases again, repeating 4 times.</description>
          </group>
          <group group_id="O6">
            <title>15.8 mg/g Concentration</title>
            <description>Participants in this arm will experience the 15.8 mg/g Concentration&#xD;
SPECTRUM cigarettes between: Participants will be assigned one of the nicotine concentrations of a SPECTRUM cigarette. They will complete a cigarette purchase task and make real purchases for the next week. Participants will return and make purchases again, repeating 4 times.</description>
          </group>
        </group_list>
        <measure>
          <title>Experimental Marketplace Purchases</title>
          <description>In all arms except the single arm, measures of quantities of experimental cigarettes and other nicotine products will be obtained.</description>
          <population>This single arm did not complete the Experimental Marketplace Purchases</population>
          <units>grams of nicotine from non-cigarettes</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="32"/>
                <count group_id="O3" value="29"/>
                <count group_id="O4" value="30"/>
                <count group_id="O5" value="31"/>
                <count group_id="O6" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Current Marketplace</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="4.07" spread="3.13"/>
                    <measurement group_id="O3" value="12.29" spread="3.47"/>
                    <measurement group_id="O4" value="15.25" spread="3.26"/>
                    <measurement group_id="O5" value="13.67" spread="3.19"/>
                    <measurement group_id="O6" value="15.25" spread="3.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Proposed Marketplace</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="12.70" spread="3.13"/>
                    <measurement group_id="O3" value="25.54" spread="3.47"/>
                    <measurement group_id="O4" value="17.42" spread="3.26"/>
                    <measurement group_id="O5" value="16.92" spread="3.19"/>
                    <measurement group_id="O6" value="14.93" spread="3.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Combined Marketplace (Usual Brand Increasing)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="4.58" spread="3.13"/>
                    <measurement group_id="O3" value="11.27" spread="3.47"/>
                    <measurement group_id="O4" value="8.34" spread="3.26"/>
                    <measurement group_id="O5" value="13.30" spread="3.19"/>
                    <measurement group_id="O6" value="7.17" spread="3.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Combined Marketplace (Experimental Cigarette Increasing)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O2" value="3.50" spread="3.13"/>
                    <measurement group_id="O3" value="9.62" spread="3.47"/>
                    <measurement group_id="O4" value="8.81" spread="3.26"/>
                    <measurement group_id="O5" value="11.36" spread="3.19"/>
                    <measurement group_id="O6" value="6.67" spread="3.31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event data were collected during the approximately 5 weeks of participation for participants in the various concentration groups (all arms other than the single arm). Adverse event data were collected during the approximately 2 months of participation for individuals in the single arm.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Single Arm</title>
          <description>All participants will complete the same experimental events across 6 laboratory sessions.&#xD;
SPECTRUM cigarettes: Across six laboratory sessions, participants will consume 10 puffs of either their usual brand of cigarette (one session) or a SPECTRUM cigarette (five sessions) with a nicotine yield varying from 0.03 to 0.70 and either menthol (TPMF codes NRC 103, NRC 201, NRC 301, NRC 401, and NRC 601) or tobacco (TPMF codes NRC 102, NRC 200, NRC 300, NRC 400, and NRC 600) flavor, depending on preference. This will be followed by the collection of blood nicotine content and a cigarette purchase task.</description>
        </group>
        <group group_id="E2">
          <title>0.4 mg/g Concentration</title>
          <description>Participants in this arm will experience the 0.4 mg/g Concentration&#xD;
SPECTRUM cigarettes between: Participants will be assigned one of the nicotine concentrations of a SPECTRUM cigarette. They will complete a cigarette purchase task and make real purchases for the next week. Participants will return and make purchases again, repeating 4 times.</description>
        </group>
        <group group_id="E3">
          <title>1.3 mg/g Concentration</title>
          <description>Participants in this arm will experience the 1.3 mg/g Concentration&#xD;
SPECTRUM cigarettes between: Participants will be assigned one of the nicotine concentrations of a SPECTRUM cigarette. They will complete a cigarette purchase task and make real purchases for the next week. Participants will return and make purchases again, repeating 4 times.</description>
        </group>
        <group group_id="E4">
          <title>2.4 mg/g Concentration</title>
          <description>Participants in this arm will experience the 2.4 mg/g Concentration&#xD;
SPECTRUM cigarettes between: Participants will be assigned one of the nicotine concentrations of a SPECTRUM cigarette. They will complete a cigarette purchase task and make real purchases for the next week. Participants will return and make purchases again, repeating 4 times.</description>
        </group>
        <group group_id="E5">
          <title>5.2 mg/g Concentration</title>
          <description>Participants in this arm will experience the 5.2 mg/g Concentration&#xD;
SPECTRUM cigarettes between: Participants will be assigned one of the nicotine concentrations of a SPECTRUM cigarette. They will complete a cigarette purchase task and make real purchases for the next week. Participants will return and make purchases again, repeating 4 times.</description>
        </group>
        <group group_id="E6">
          <title>15.8 mg/g Concentration</title>
          <description>Participants in this arm will experience the 15.8 mg/g Concentration&#xD;
SPECTRUM cigarettes between: Participants will be assigned one of the nicotine concentrations of a SPECTRUM cigarette. They will complete a cigarette purchase task and make real purchases for the next week. Participants will return and make purchases again, repeating 4 times.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="97"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="44"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="97"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="47"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="37"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="44"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Food poisoning</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="97"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="44"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="97"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="44"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="97"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="44"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Life Events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="97"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="37"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="44"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Gall Bladder removal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="97"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="37"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="44"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="97"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="47"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="44"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Vomit after cigarette and alcohol consumption</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="97"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="44"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="97"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="44"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="97"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="47"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="44"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Life events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="97"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="41"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="47"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="39"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="44"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Mikhail Koffarnus</name_or_title>
      <organization>University of Kentucky</organization>
      <phone>8593236402</phone>
      <email>koffarnus@uky.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

